BMY
Price
$48.34
Change
+$0.45 (+0.94%)
Updated
Apr 28, 04:31 PM (EDT)
Capitalization
109.66B
94 days until earnings call
PFE
Price
$23.02
Change
+$0.10 (+0.44%)
Updated
Apr 28, 04:55 PM (EDT)
Capitalization
157.14B
One day until earnings call
Ad is loading...

BMY vs PFE

Header iconBMY vs PFE Comparison
Open Charts BMY vs PFEBanner chart's image
Bristol-Myers Squibb
Price$48.34
Change+$0.45 (+0.94%)
Volume$14.04K
Capitalization109.66B
Pfizer
Price$23.02
Change+$0.10 (+0.44%)
Volume$130K
Capitalization157.14B
BMY vs PFE Comparison Chart
Loading...
BMY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PFE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BMY vs. PFE commentary
Apr 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BMY is a Hold and PFE is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 28, 2025
Stock price -- (BMY: $47.90 vs. PFE: $22.92)
Brand notoriety: BMY and PFE are both notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: BMY: 119% vs. PFE: 66%
Market capitalization -- BMY: $109.66B vs. PFE: $157.14B
BMY [@Pharmaceuticals: Major] is valued at $109.66B. PFE’s [@Pharmaceuticals: Major] market capitalization is $157.14B. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $739.66B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $86.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BMY’s FA Score shows that 1 FA rating(s) are green whilePFE’s FA Score has 1 green FA rating(s).

  • BMY’s FA Score: 1 green, 4 red.
  • PFE’s FA Score: 1 green, 4 red.
According to our system of comparison, both BMY and PFE are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BMY’s TA Score shows that 4 TA indicator(s) are bullish while PFE’s TA Score has 4 bullish TA indicator(s).

  • BMY’s TA Score: 4 bullish, 5 bearish.
  • PFE’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, BMY is a better buy in the short-term than PFE.

Price Growth

BMY (@Pharmaceuticals: Major) experienced а -2.70% price change this week, while PFE (@Pharmaceuticals: Major) price change was +3.52% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was +4.93%. For the same industry, the average monthly price growth was -1.15%, and the average quarterly price growth was -8.10%.

Reported Earning Dates

BMY is expected to report earnings on Jul 31, 2025.

PFE is expected to report earnings on Aug 05, 2025.

Industries' Descriptions

@Pharmaceuticals: Major (+4.93% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PFE($157B) has a higher market cap than BMY($110B). PFE has higher P/E ratio than BMY: PFE (74.92) vs BMY (13.73). PFE YTD gains are higher at: -12.179 vs. BMY (-13.448). BMY has higher annual earnings (EBITDA): 19.4B vs. PFE (9.56B). PFE (12.7B) and BMY (12.3B) have equal amount of cash in the bank . BMY has less debt than PFE: BMY (41.5B) vs PFE (70.8B). PFE has higher revenues than BMY: PFE (58.5B) vs BMY (45B).
BMYPFEBMY / PFE
Capitalization110B157B70%
EBITDA19.4B9.56B203%
Gain YTD-13.448-12.179110%
P/E Ratio13.7374.9218%
Revenue45B58.5B77%
Total Cash12.3B12.7B97%
Total Debt41.5B70.8B59%
FUNDAMENTALS RATINGS
BMY vs PFE: Fundamental Ratings
BMY
PFE
OUTLOOK RATING
1..100
6219
VALUATION
overvalued / fair valued / undervalued
1..100
5
Undervalued
3
Undervalued
PROFIT vs RISK RATING
1..100
80100
SMR RATING
1..100
9772
PRICE GROWTH RATING
1..100
6263
P/E GROWTH RATING
1..100
9298
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

PFE's Valuation (3) in the Pharmaceuticals Major industry is in the same range as BMY (5). This means that PFE’s stock grew similarly to BMY’s over the last 12 months.

BMY's Profit vs Risk Rating (80) in the Pharmaceuticals Major industry is in the same range as PFE (100). This means that BMY’s stock grew similarly to PFE’s over the last 12 months.

PFE's SMR Rating (72) in the Pharmaceuticals Major industry is in the same range as BMY (97). This means that PFE’s stock grew similarly to BMY’s over the last 12 months.

BMY's Price Growth Rating (62) in the Pharmaceuticals Major industry is in the same range as PFE (63). This means that BMY’s stock grew similarly to PFE’s over the last 12 months.

BMY's P/E Growth Rating (92) in the Pharmaceuticals Major industry is in the same range as PFE (98). This means that BMY’s stock grew similarly to PFE’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BMYPFE
RSI
ODDS (%)
Bullish Trend 7 days ago
53%
Bullish Trend 7 days ago
63%
Stochastic
ODDS (%)
Bullish Trend 7 days ago
49%
Bullish Trend 7 days ago
45%
Momentum
ODDS (%)
Bearish Trend 7 days ago
55%
N/A
MACD
ODDS (%)
N/A
Bearish Trend 7 days ago
54%
TrendWeek
ODDS (%)
Bearish Trend 7 days ago
52%
Bullish Trend 7 days ago
55%
TrendMonth
ODDS (%)
Bearish Trend 7 days ago
50%
Bearish Trend 7 days ago
59%
Advances
ODDS (%)
Bullish Trend 15 days ago
55%
Bullish Trend 14 days ago
56%
Declines
ODDS (%)
Bearish Trend 8 days ago
53%
Bearish Trend 21 days ago
60%
BollingerBands
ODDS (%)
Bullish Trend 7 days ago
67%
Bullish Trend 7 days ago
52%
Aroon
ODDS (%)
Bearish Trend 7 days ago
47%
Bearish Trend 7 days ago
58%
View a ticker or compare two or three
Ad is loading...
BMY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PFE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TSLA284.9525.44
+9.80%
Tesla
GME27.460.38
+1.40%
GameStop Corp
SPY550.643.95
+0.72%
SPDR® S&P 500® ETF
AAPL209.280.91
+0.44%
Apple
BTC.X93754.840000-892.085940
-0.94%
Bitcoin cryptocurrency

BMY and

Correlation & Price change

A.I.dvisor indicates that over the last year, BMY has been loosely correlated with PFE. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if BMY jumps, then PFE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BMY
1D Price
Change %
BMY100%
-1.62%
PFE - BMY
43%
Loosely correlated
+0.61%
GILD - BMY
40%
Loosely correlated
-2.81%
JNJ - BMY
39%
Loosely correlated
-0.23%
AMGN - BMY
33%
Poorly correlated
+0.36%
OGN - BMY
31%
Poorly correlated
+0.66%
More

PFE and

Correlation & Price change

A.I.dvisor indicates that over the last year, PFE has been loosely correlated with JNJ. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if PFE jumps, then JNJ could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PFE
1D Price
Change %
PFE100%
+0.61%
JNJ - PFE
54%
Loosely correlated
-0.23%
GSK - PFE
51%
Loosely correlated
-0.19%
AMGN - PFE
48%
Loosely correlated
+0.36%
OGN - PFE
46%
Loosely correlated
+0.66%
NVS - PFE
46%
Loosely correlated
+0.87%
More